Synthesis and physicochemical characterization of acyl myricetins as potential anti-neuroexocytotic agents

Acyl myricetins (monopropionyl-, dipropionyl-, and monooctanoyl-myricetin, termed as MP 1 , MP 2 , and MO 1 , respectively) were synthesized through enzymatic or non-enzymatic esterification reaction of myricetin aglycone. Structure study indicated the hydroxyl group at C4′ in B-ring was highly susc...

Full description

Saved in:
Bibliographic Details
Published inScientific reports Vol. 13; no. 1; p. 5136
Main Authors Cho, Sora, Kong, Byoungjae, Jung, Younghun, Shin, Jonghyeok, Park, Myungseo, Chung, Woo-Jae, Ban, Choongjin, Kweon, Dae-Hyuk
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 29.03.2023
Nature Publishing Group
Nature Portfolio
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Acyl myricetins (monopropionyl-, dipropionyl-, and monooctanoyl-myricetin, termed as MP 1 , MP 2 , and MO 1 , respectively) were synthesized through enzymatic or non-enzymatic esterification reaction of myricetin aglycone. Structure study indicated the hydroxyl group at C4′ in B-ring was highly susceptible to acylation. Over its parental myricetin, acylated compounds showed enhanced lipophilicity (from 7.4- to 26.3-fold) and oxidative stability (from 1.9- to 3.1-fold) on the basis of log P and decay rate, respectively. MO 1 , presenting the physicochemical superiority compared to the others, provided lowest EC 50 value of 2.51 μM on inhibition of neutrotransmitter release and CC 50 value of 59.0 μM, leading to widest therapeutic window. All myricetin esters did not show any irritation toxicity when assessed with a chicken embryo assay. This study describes information on acylation of myricetin that has not yet been explored, and suggests that MO 1 has membrane fusion-arresting and anti-neuroexocytotic potential for industrial application due to its enhanced biological properties.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2045-2322
2045-2322
DOI:10.1038/s41598-023-32361-6